The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

A trade group representing compounding pharmacies sued the FDA for a “reckless and arbitrary” decision to remove Eli Lilly's ...

A growing number of employers are considering covering the blockbuster weight-loss drugs, several surveys show. Workers will ...

WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

Drug makers have responded by setting list prices of about $1,000 per month per patient. People with obesity have wrestled with people with diabetes over access to the drugs. Workers have sued ...

Kailera Therapeutics has launched into the increasingly crowded obesity space with a portfolio of assets acquired from China ...

The report shows a rise in medication use, obesity, and smoking, a decline in cancer screenings, concerns over excessive ...

The list price for Wegovy, for instance, is about $1,350 for a four-week supply. Nearly 40 million people with employer coverage are estimated to be eligible for anti-obesity medications based on ...